Javascript must be enabled to continue!
Unquantifiable: The Impacts of Len Vacher
View through CrossRef
This article celebrates H.L. (Len) Vacher, the founding editor of Numeracy. While many readers of this journal are no doubt familiar with Len’s contributions here and to quantitative literacy as a practice and habit of mind, fewer are intimately familiar with Len’s history and impacts as a professor and colleague. This paper analyzes Len's contributions to the advancement of quantitative literacy through his scholarship in the journal and through the careers of former students and colleagues at the University of South Florida. The former observations originate in interview data originally collected as part of research on Len’s computational geology course or from testimonials given at Len’s retirement banquet. This editorial-style paper is not intended as research and makes no attempt to analyze the collected quotes, but rather offers select quotes to shed light on a side of Len Vacher's work that is not observable in his scholarly output alone.
Title: Unquantifiable: The Impacts of Len Vacher
Description:
This article celebrates H.
L.
(Len) Vacher, the founding editor of Numeracy.
While many readers of this journal are no doubt familiar with Len’s contributions here and to quantitative literacy as a practice and habit of mind, fewer are intimately familiar with Len’s history and impacts as a professor and colleague.
This paper analyzes Len's contributions to the advancement of quantitative literacy through his scholarship in the journal and through the careers of former students and colleagues at the University of South Florida.
The former observations originate in interview data originally collected as part of research on Len’s computational geology course or from testimonials given at Len’s retirement banquet.
This editorial-style paper is not intended as research and makes no attempt to analyze the collected quotes, but rather offers select quotes to shed light on a side of Len Vacher's work that is not observable in his scholarly output alone.
Related Results
Evaluation of Atezolizumab Plus Bevacizumab Versus Modified Lenvatinib Therapy in Child-Pugh A Unresectable Hepatocellular Carcinoma
Evaluation of Atezolizumab Plus Bevacizumab Versus Modified Lenvatinib Therapy in Child-Pugh A Unresectable Hepatocellular Carcinoma
Background/Aim: Atezolizumab/bevacizumab (Atez/BV) and lenvatinib (LEN) are the recommended first-line treatments for patients with unresectable hepatocellular carcinoma (HCC). Pre...
HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study
HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study
Abstract
Background
The treatment of hepatocellular carcinoma (HCC) patients exhibiting high-risk characteristics (Vp4, and/or bile duct invasion, a...
Aplikasi My Len Untuk Menghubungkan Branding, Komunikasi Pemasaran, dan Penjualan dalam Satu Platform Digital Terintegrasi di PT Len Pesero
Aplikasi My Len Untuk Menghubungkan Branding, Komunikasi Pemasaran, dan Penjualan dalam Satu Platform Digital Terintegrasi di PT Len Pesero
Penelitian ini bertujuan agar penulis menemukan media interaktif terintegrasi yang dapat menghubungkan branding, komunikasi pemasaran, dan penjualan untuk mempercepat proses bisnis...
Safety and efficacy of DEB-TACE in combination with lenvatinib and camrelizumab for the treatment of unresectable hepatocellular carcinoma (uHCC): a two-centre retrospective study
Safety and efficacy of DEB-TACE in combination with lenvatinib and camrelizumab for the treatment of unresectable hepatocellular carcinoma (uHCC): a two-centre retrospective study
ObjectivesThe purpose of this study was to compare the safety and efficacy of drug-eluting bead (DEB) transarterial chemoembolization combined with lenvatinib and camrelizumab (DEB...
Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma
Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma
Multiple Myeloma (MM) is an incurable neoplasm of mature B cells and the second most prevalent hematological malignancy worldwide. While combinations of proteasome inhibitors like ...
Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion
Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion
Objectives
In thyroid cancer with marked laryngotracheal invasion, life-threatening airway stenosis necessitates urgent procedures such as extensive curative su...
Abstract 3723: Regulation of TRAIL-induced apoptotic signaling by the autophagy receptor p62 in acute promyelocytic leukemia cells
Abstract 3723: Regulation of TRAIL-induced apoptotic signaling by the autophagy receptor p62 in acute promyelocytic leukemia cells
Abstract
Autophagy is an evolutionary conserved process that degrades and recycles cellular components through the lysosomal pathway to maintain cellular homeostasis...
Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in Multiple Myeloma
Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in Multiple Myeloma
Abstract
Purpose
Multiple Myeloma (MM) is an incurable neoplasm of mature B cells and the second most prevalent hematological malignancy worldwide. While combinations of p...

